EWA
HRMY icon

Evolution Wealth Advisors’s Harmony Biosciences HRMY Stock Holding History

Evolution Wealth Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-107
Closed -$4K – 363
2021
Q3 		$4K Sell
107
-185
-63% -$5.96K ﹤0.01% 556
2021
Q2 		$8K Buy
292
+33
+13% +$990 ﹤0.01% 442
2021
Q1 		$9K Buy
259
+15
+6% +$526 ﹤0.01% 428
2020
Q4 		$9K Buy
+244
New +$9.85K ﹤0.01% 359

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Evolution Wealth Advisors's HRMY Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Harmony Biosciences (HRMY) in Q4 2021, closing a stake of 107 shares — an estimated $4K sold.

Evolution Wealth Advisors first reported a position in HRMY in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q1 2021. 147 funds tracked by Wall St. Rank hold HRMY as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Harmony Biosciences position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 107 Harmony Biosciences shares in Q4 2021, an estimated $4K.
  • Evolution Wealth Advisors first reported a position in Harmony Biosciences in Q4 2020 and held it in 4 quarters.
  • Evolution Wealth Advisors's Harmony Biosciences position peaked at $9K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.